STOCKHOLDERS’ DEFICIT

12 Months Ended

Mar. 31, 2023

Equity [Abstract]

STOCKHOLDERS’ DEFICIT

NOTE – 8 STOCKHOLDERS’ DEFICIT

The Company is authorized to issue two classes of capital stock, up to 6,085,000,000 shares.

The Company is authorized to issue 85,000,000 shares of preferred stock, with a par value of $0.001. The Company has one class of Preferred Stock designated with 50,000,000 shares authorized as Series C Preferred Stock, with a par value of $0.001 per share.

The Company is authorized to issue 6,000,000,000 shares of common stock, with a par value of $0.001.

Series C Preferred Stock

The Company has designated 50,000,000 shares of Series C Preferred Stock. Each one share of Series C Convertible Preferred Stock converts into 100 shares of common stock of the Company at the election of the holder, subject to equitable adjustments.

As of March 31, 2023 and 2022, the Company had 30,000,000 shares of Series C Preferred Stock issued and outstanding.

Common Stock

On June 24, 2022, the Company issued 525,000,000 shares of its common stock as Commitment Shares to Williamsburg Venture Holdings, LLC (the “Investor”), under an Equity Purchase Agreement dated June 21, 2022 (the “Agreement”), in consideration for the Investor’s execution and delivery of, and performance under the Agreement, which was deferred to be amortized over the financing period of 36 months.

On August 12, 2022, the Company issued 151,515,152 shares of its common stock to settle the accrued consulting and service fee to consultants who provided the prior services to the Company.

On September 30, 2022, the Company cancelled 150,000 shares of its common stock due to an error noted from previous transfer agent’s record.

As of March 31, 2023 and 2022, the Company had a total of 5,484,167,213 shares and 4,807,802,061 shares of common stock issued and outstanding, respectively.